Cardio Diagnostics Holdings, Inc.(CDIO)

Biotechnology · Chicago, IL

$2.05-0.01 (-0.49%)

Delayed quote: Oct 6, 2026, 12:13 PM EDT

Cardio Diagnostics Holdings (CDIO) Price/OCF Ratio: History & Chart | TGMCharts

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T16:16:06.515Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:16:06.515Z.

Quote observation: 2026-10-06T16:13:26.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 6,066,911
TTM operating cash flow · period ending 2026-06-30: -5,659,843

FMP input reference: 9b4bc62a31f75b1a016fc6ea0dc71fcb65437a541a8d62a03c8decabfd044c64

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CDIO Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

CDIO Competitors' Price/OCF Ratio

CDIO

Cardio Diagnostics Holdings, Inc.

Current

Market Cap

$6.07M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENLV

Enlivex Therapeutics Ltd.

vs CDIO

Market Cap

$5.98M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCNX

Scienture Holdings, Inc.

vs CDIO

Market Cap

$6.10M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCY

Lucyd, Inc

vs CDIO

Market Cap

$5.85M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FEMY

Femasys Inc.

vs CDIO

Market Cap

$6.16M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACXP

Acurx Pharmaceuticals, Inc.

vs CDIO

Market Cap

$5.72M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs CDIO

Market Cap

$5.77M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVNO

enVVeno Medical Corporation

vs CDIO

Market Cap

$5.60M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMRA

Biomerica, Inc.

vs CDIO

Market Cap

$6.54M

Price/OCF Ratio

N/A

TTM Avg

119.62

3Y Avg

119.62

5Y Avg

119.62

ENSC

Ensysce Biosciences, Inc.

vs CDIO

Market Cap

$6.43M

Price/OCF Ratio

N/A

TTM Avg

1251.33

3Y Avg

3596.77

5Y Avg

3596.77

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Cardio Diagnostics Holdings, Inc. (CDIO)	$6.07M	N/A	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$5.98M	N/A	N/A	N/A	N/A
Scienture Holdings, Inc. (SCNX)vs ›	$6.10M	N/A	N/A	N/A	N/A
Lucyd, Inc (LUCY)vs ›	$5.85M	N/A	N/A	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.16M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.72M	N/A	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.77M	N/A	N/A	N/A	N/A
enVVeno Medical Corporation (NVNO)vs ›	$5.60M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.54M	N/A	119.62	119.62	119.62
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.43M	N/A	1251.33	3596.77	3596.77

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

CDIO Price/OCF Ratio Metrics

CDIO Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics